John Boyer Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.05M Buy
72,030
+3,733
+5% +$99.3K 1.62% 14
2026
Q2
$1.64M Buy
68,297
+1,614
+2% +$42.2K 1.43% 15
2026
Q1
$1.87M Buy
66,683
+5,971
+10% +$159K 1.87% 12
2025
Q4
$1.51M Buy
60,712
+21,934
+57% +$553K 1.54% 14
2025
Q3
$988K Buy
+38,778
New +$957K 0.99% 17

Other funds holding PFE

John Boyer Inc's PFE Position: Q3 2026 in Review

John Boyer Inc increased its Pfizer (PFE) stake by 5.5% in Q3 2026, buying an estimated $99.3K and bringing the position to 72,030 shares worth $2.05M. The position accounts for 1.62% of the portfolio, ranked #14.

John Boyer Inc first reported a position in PFE in Q3 2025 and has held it in 5 quarters since. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • John Boyer Inc held 72,030 shares of Pfizer worth $2.05M as of Q3 2026.
  • John Boyer Inc bought 3,733 Pfizer shares in Q3 2026, an estimated $99.3K.
  • Pfizer made up 1.62% of John Boyer Inc's portfolio in Q3 2026, its #14 holding.
  • John Boyer Inc first reported a position in Pfizer in Q3 2025 and has held it in 5 quarters since.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on John Boyer Inc's 13F filing for Q3 2026, filed 27 Oct 2026.